NASDAQ:TEM - Nasdaq - US88023B1035 - Common Stock - Currency: USD
Intrigued by the market activity in the middle of the day on Wednesday? Uncover the key winners and losers of today's session in our insightful analysis.
Let's have a look at the gap up and gap down stocks in today's session.
Tempus AI was targeted by a short seller last week. Since then, the company has made several announcements that have helped quell doubts introduced by the short report. The company's stock jumped 15% as of market close.
The company stated that the assay, currently available for research use, will be clinically available later this year.
Tempus AI Inc (NASDAQ:TEM) shares are moving higher Monday after the company introduced a new program to monitor immunotherapy response for patients with advanced cancer.
Here are Cathie Wood’s latest buys.
Berkshire Hathaway remains an attractive investment despite its upcoming leadership change. Vertex Pharmaceuticals has room to grow in its core market and continues to innovate in new areas. Two great examples are Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) and Vertex Pharmaceuticals (NASDAQ: VRTX).
Prologis, MPLX, and McCormick are three dividend growth stocks with yields that are more than double the market average at recent prices. Patient investors could receive double-digit percentage yields from these stocks down the road. High-yield dividend stocks are great, but you know what's even better?
The health care AI startup has responded to some scathing accusations.
Mentions: COF
/PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of...
We recently published a list of 10 Stocks Crash Harder Than Wall Street. In this article, we are going to take a look at where Tempus AI, Inc. (NASDAQ:TEM) stands against other worst-performing stocks. Tempus AI nosedived by 19.23 percent on Wednesday to close at $53.20 apiece following a short-seller report’s negative comments and concerns about […]
On Wednesday, May 28, Motorola Solutions Inc. (NYSE:MSI) announced its acquisition of privately held Silvus Technologies Inc., a wireless radio manufacturer specializing in MIMO (Multiple Input, Multiple Output) communication technology. The all-cash deal is valued at $4.4 billion. Silvus was previously owned by private equity firm TJC (earlier known as The Jordan Company), which acquired […]
On May 28, Wells Fargo analyst Mike Mayo reiterated a Buy rating on Bank of America Corp. (NYSE:BAC) with an unchanged price target of $56. Mayo believes that Bank of America has significantly strengthened its balance sheet over the last 15 years, as evidenced by its performance in the Federal Reserve’s stress tests. Additionally, the […]
An investment management firm known for short-selling the stocks it speaks against is now targeting a high-risk, high-reward stock purchased by a high-profile politician.
The report stated that Tempus AI’s management and board members have a history of promoting “disruptive technology companies” and cashing out early.